145 related articles for article (PubMed ID: 29282497)
21. Characterizing the learning curve of MRI-US fusion prostate biopsies.
Halstuch D; Baniel J; Lifshitz D; Sela S; Ber Y; Margel D
Prostate Cancer Prostatic Dis; 2019 Dec; 22(4):546-551. PubMed ID: 30842585
[TBL] [Abstract][Full Text] [Related]
22. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
23. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of real-time magnetic resonance imaging-transrectal ultrasound fusion image-guided transperineal target biopsy with needle tracking with a mechanical position-encoded stepper in detecting significant prostate cancer in biopsy-naïve men.
Shoji S; Hiraiwa S; Ogawa T; Kawakami M; Nakano M; Hashida K; Sato Y; Hasebe T; Uchida T; Tajiri T
Int J Urol; 2017 Apr; 24(4):288-294. PubMed ID: 28222486
[TBL] [Abstract][Full Text] [Related]
25. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
26. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.
Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R
BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477
[TBL] [Abstract][Full Text] [Related]
27. Magnetic resonance imaging-transrectal ultrasound image fusion guidance of prostate biopsies: current status, challenges and future perspectives.
Boesen L
Scand J Urol; 2019; 53(2-3):89-96. PubMed ID: 31006323
[TBL] [Abstract][Full Text] [Related]
28. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.
Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA
Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865
[TBL] [Abstract][Full Text] [Related]
29. Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR.
Rosenkrantz AB; Verma S; Choyke P; Eberhardt SC; Eggener SE; Gaitonde K; Haider MA; Margolis DJ; Marks LS; Pinto P; Sonn GA; Taneja SS
J Urol; 2016 Dec; 196(6):1613-1618. PubMed ID: 27320841
[TBL] [Abstract][Full Text] [Related]
30. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
[TBL] [Abstract][Full Text] [Related]
31. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy.
Singh AK; Kruecker J; Xu S; Glossop N; Guion P; Ullman K; Choyke PL; Wood BJ
BJU Int; 2008 Apr; 101(7):841-5. PubMed ID: 18070196
[TBL] [Abstract][Full Text] [Related]
32. Are Magnetic Resonance Imaging-Transrectal Ultrasound Guided Targeted Biopsies Noninferior to Transrectal Ultrasound Guided Systematic Biopsies for the Detection of Prostate Cancer?
Delongchamps NB; Portalez D; Bruguière E; Rouvière O; Malavaud B; Mozer P; Fiard G; Cornud F;
J Urol; 2016 Oct; 196(4):1069-75. PubMed ID: 27079582
[TBL] [Abstract][Full Text] [Related]
33. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
[TBL] [Abstract][Full Text] [Related]
34. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer.
Panebianco V; Valerio MC; Giuliani A; Pecoraro M; Ceravolo I; Barchetti G; Catalano C; Padhani AR
Eur Urol Oncol; 2018 Aug; 1(3):208-214. PubMed ID: 31102623
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy.
Cool DW; Zhang X; Romagnoli C; Izawa JI; Romano WM; Fenster A
AJR Am J Roentgenol; 2015 Jan; 204(1):83-91. PubMed ID: 25539241
[TBL] [Abstract][Full Text] [Related]
36. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
[TBL] [Abstract][Full Text] [Related]
37. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
38. Comparative Effectiveness of Targeted Prostate Biopsy Using Magnetic Resonance Imaging Ultrasound Fusion Software and Visual Targeting: a Prospective Study.
Lee DJ; Recabal P; Sjoberg DD; Thong A; Lee JK; Eastham JA; Scardino PT; Vargas HA; Coleman J; Ehdaie B
J Urol; 2016 Sep; 196(3):697-702. PubMed ID: 27038768
[TBL] [Abstract][Full Text] [Related]
39. Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience.
Shoji S; Hiraiwa S; Endo J; Hashida K; Tomonaga T; Nakano M; Sugiyama T; Tajiri T; Terachi T; Uchida T
Int J Urol; 2015 Feb; 22(2):173-8. PubMed ID: 25316213
[TBL] [Abstract][Full Text] [Related]
40. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy.
Kenigsberg AP; Renson A; Rosenkrantz AB; Huang R; Wysock JS; Taneja SS; Bjurlin MA
Eur Urol Oncol; 2018 Oct; 1(5):418-425. PubMed ID: 31158081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]